Pretreatment tumor diameter/volume and pelvic lymph node status assessed by magnetic resonance imaging for uterine cervical carcinoma treated with concurrent chemotherapy and radiotherapy

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue 4, 2008, Pages 529-537

  Kim, Hun Jung ^a   Kim, Woo Chul ^a  

^a Inha University Hospital   (South Korea)

Author keywords

Cervical cancer; Lymph node; Magnetic resonance imaging (MRI); Radiotherapy; Tumor volume

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS LYMPH NODE; PROGNOSIS; SCORING SYSTEM; TUMOR VOLUME; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 50049105443     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00733.x     Document Type: Article

References (49)

1. Hopkins MP, Morley GW. Stage IB squamous cell cancer of the cervix: Clinicopathologic features related to survival. Am J Obstet Gynecol 1991 164 : 1520 1527.
2. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990 38 : 352 357.
3. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Onocol Biol Phys 1994 29 : 9 16.
4. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1028 cervical cancers studied with volume try. Cancer 1998 70 : 648 655.
5. Alvarez RD, Soong SJ, Kinney WK et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 1989 35 : 130 135.
6. Kovalic JJ, Perez CA, Grigsby PW, Lockett M. The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1991 21 : 905 910.
7. Averette HE, Ford JH, Dudan RC, Girtanner RE, Hoskins WJ, Lutz MH. Staging of cervical cacner. Clin Obstet Gynecol 1975 18 : 215 232.
8. Heyman J, Kottmeier HL, Segerdahl CO. An investigation of the reliability of stage grouping in cancer of the uterine cervix. Acta Obstet Gynecol Scand 1953 32 : 65 79.
9. Van Nagell JRJ, Roddick JW, Lowin DM. The staging of cervical cancer: Inevitable discrepancies between clinical staging and pathologic findings. Am J Obstet Gynecol 1971 10 : 973 978.
10. Burghardt E, Hofmann HM, Ebner F, Haas J, Tamussino K, Justich E. Magnetic resonance imaging in cervical cancer: A basis for objective classification. Gynecol Oncol 1989 33 : 61 67.
11. Subak L, Hricak H, Powell C, Azizi L, Stern J. Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995 86 : 43 50.
12. Mayr NA, Yuh WT, Zheng J et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997 39 : 395 404.
13. Martin AJ, Poon CS, Thomas GM et al. MR evaluation of cervical cancer in hysterectomy specimens: Correlation of quantitative T2 measurement and histology. J Magn Reson Imaging 1994 4 : 779 786.
14. Hricak H, Quivey J, Campos Z et al. Carcinoma of the cervix: Predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993 27 : 791 801.
15. Narayan K, McKenzie A, Fisher R, Susil B, Jobing T, Bernshaw D. Estimation of tumor volume in cervical cancer by magnetic resonance imaging. Am J Clin Oncol 2003 26 : 163 168.
16. Hofman HM, Ebner F, Haas J et al. Magnetic resonance imaging in clinical cervical cancer: Pretherapeutic tumor volume try. Baillieres Clin Obstet Gynaecol 1988 2 : 789 802.
17. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999 340 : 1137 1143.
18. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 340 : 1144 1153.
19. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999 17 : 1339 1348.
20. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncologic Group. Gynecol Oncol 1980 9 : 90 98.
21. Narayan K, Fisher R, Bernshaw D. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer 2006 16 : 623 630.
22. Kodaira T, Fuwa N, Toita T et al. Clinical evaluation using Magnetic Resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis; its usefulness and limitations in clinical practice. Am J Clin Oncol 2003 26 : 574 583.
23. Wagenaar HC, Trimbos JBM, Postema S et al. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 2001 82 : 474 482.
24. Kilcheski TS, Arger PH, Mulhern CBJ, Coleman BG, Kressel HY, Mikuta JI. Role of computed tomography in the presurgical evaluation of carcinoma of the cervix. J Comput Assist Tomogr 1981 5 : 378 383.
25. Vas W, Wolverson M, Freel J, Salimi Z, Sundaram M. Computed tomography in the pretreatment assessment of carcinoma of the cervix. J Comput Tomogr 1985 9 : 359 368.
26. Kim SH, Choi BI, Lee HP et al. Uterine cervical carcinoma: Comparison of CT and MR findings. Radiology 1990 175 : 45 51.
27. Greco A, Mason P, Leung AWL, Dische S, Mclndoe GAJ, Anderson MC. Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol 1989 40 : 401 405.
28. Rubens D, Thornbury JR, Angel C et al. Stage IB cervical carcinoma: Comparison of clinical, MR, and pathologic staging. AJR Am J Roentgenol 1998 150 : 135 138.
29. Sironi S, Belloni C, De Taccagni GI, Maschio A. Carcinoma of the cervix: Value of MR imaging in detecting parametrial involvement. AJR Am J Roentgenol 1991 156 : 753 756.
30. Toita T, Kakinohana Y, Shinzato S et al. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys 1999 43 : 777 782.
31. Mayr NA, Tali ET, Yuh WT et al. Cervical cancer: Application of MR imaging in radiation therapy. Radiology 1993 189 : 601 608.
32. Hricak H, Lacey CG, Sandles LG et al. Invasive cervical carcinoma: Comparison of MR imaging and surgical findings. Radiology 1988 166 : 623 631.
33. Oellinger JJ, Blohmer JU, Michniewicz K et al. Pre-operative staging of cervical cancer: Comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynackol 2000 122 : 82 91.
34. Manfredi R, Maresca G, Smaniotto D et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology 1998 209 : 819 824.
35. Hawnaur JM, Johnson RJ, Buckley CH et al. Staging, volume estimation and assessment of nodal status in carcinoma of cervix: Comparison of magnetic resonance imaging with surgical findings. Clin Radiol 1994 49 : 443 452.
36. Kodaira T, Fuwa N, Kamata M et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: Are all patients with stage II disease suitable candidate for chemoradiotherapy? Int J Radiat Oncol Biol Phys 2002 52 : 627 636.
37. Kodaira T, Fuwa N, Toita T et al. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003 56 : 769 777.
38. Kamura T, Shigematsu T, Kaku T et al. Histopathologic factor influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand 1999 78 : 452 457.
39. Noguchi H, Shiozawa K, Tsukamoto T, Tsukahara Y, Iwai S, Fukuta T. The postoperative classification for uterine cervical cancer and its clinical evaluation. Gynecol Oncol 1993 16 : 219 231.
40. Lanciano RM, Corn BW. The role of surgical staging for cervical cancer. Semin Radiat Oncol 1994 4 : 46 51.
41. Hsu CT, Cheng YS, Su SC. Prognosis of uterine cervical cancer with extensive lymph node metastases. Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol 1972 114 : 954 962.
42. Lapolla JP, Schlaerth JB, Gaddis O, Morrow CP. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 1986 24 : 194 206.
43. Rutledge FN, Mitchell MF, Nunsell S et al. Youth as a prognostic factor in carcinoma of the cervix: A matched analysis. Gynecol Oncol 1992 44 : 123 130.
44. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999 43 : 763 775.
45. Delaloye JF, Pampallona S, Coucke PA et al. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol 1996 64 : 201 205.
46. Reagan JW, Fu YS. Histologic types and prognosis of cancers of the uterine cervix. Int J Radiat Oncol Biol Phys 1979 5 : 1015 1020.
47. Gunderson LL, Weems WS, Hebertson RM et al. Correlation of histopathology with clinical results following radiation therapy for carcinoma of cervix. Am J Roentgenol Radium Ther Nucl Med 1974 120 : 74 87.
48. Crissman JD, Budhraja M, Aron BS et al. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol 1987 6 : 97 103.
49. Finan MA, DeCesare S, Fiorica JV et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Dose the new staging system predict morbidity and survival? Gynecol Oncol 1996 62 : 139 147.